{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:58Z","timestamp":1792047838480,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1344,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-DK090548"],"award-info":[{"award-number":["R21-DK090548"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1-DK090058"],"award-info":[{"award-number":["RO1-DK090058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005674","name":"Cystinosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/mt.2012.214","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T08:24:15Z","timestamp":1350980655000},"page":"433-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Hematopoietic Stem Cell Gene Therapy for the Multisystemic Lysosomal Storage Disorder Cystinosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Frank","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A","family":"Yeagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine J","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Cherqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.214_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00062752-199911000-00004","article-title":"Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome","volume":"6","author":"Krivit","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/mt.2012.214_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beha.2008.02.006","article-title":"Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity","volume":"21","author":"Johnston","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1038\/mt.2012.214_bib3","first-page":"223","article-title":"Managing the toxicity of hematopoietic stem cell transplant","volume":"2","author":"Pallera","year":"2004","journal-title":"J Support Oncol"},{"key":"10.1038\/mt.2012.214_bib4","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2006-09-046219","article-title":"Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation","volume":"109","author":"Cutler","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2012.214_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2141.2011.08822.x","article-title":"A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients","volume":"155","author":"Geyer","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2012.214_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2008.377","article-title":"Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study","volume":"43","author":"Schleuning","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/mt.2012.214_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/187152611794407764","article-title":"Challenges and advances in infection control of hematopoietic stem cell transplant recipients","volume":"11","author":"Magauran","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"10.1038\/mt.2012.214_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.idc.2010.01.010","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"24","author":"Wingard","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1038\/mt.2012.214_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.2011.301","article-title":"Cysteamine therapy: a treatment for cystinosis, not a cure","volume":"81","author":"Cherqui","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2012.214_bib10","doi-asserted-by":"crossref","first-page":"13314","DOI":"10.1074\/jbc.M010562200","article-title":"The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif","volume":"276","author":"Cherqui","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2012.214_bib11","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1093\/emboj\/20.21.5940","article-title":"Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter","volume":"20","author":"Kalatzis","year":"2001","journal-title":"EMBO J"},{"key":"10.1038\/mt.2012.214_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng0498-319","article-title":"A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis","volume":"18","author":"Town","year":"1998","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2012.214_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMra020552","article-title":"Cystinosis","volume":"347","author":"Gahl","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.214_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpeds.2004.03.056","article-title":"Long-term follow-up of well-treated nephropathic cystinosis patients","volume":"145","author":"Kleta","year":"2004","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2012.214_bib15","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s00467-010-1641-8","article-title":"Long-term outcome of nephropathic cystinosis: a 20-year single-center experience","volume":"25","author":"Greco","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/mt.2012.214_bib16","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1128\/MCB.22.21.7622-7632.2002","article-title":"Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis","volume":"22","author":"Cherqui","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1038\/mt.2012.214_bib17","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood-2009-03-213934","article-title":"Successful treatment of the murine model of cystinosis using bone marrow cell transplantation","volume":"114","author":"Syres","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2012.214_bib18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ki.2010.537","article-title":"Kidney preservation by bone marrow cell transplantation in hereditary nephropathy","volume":"79","author":"Yeagy","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2012.214_bib19","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1073\/pnas.96.6.2988","article-title":"Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors","volume":"96","author":"Case","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.214_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.283.5402.682","article-title":"Transduction of human CD34+ cells that mediate long-term engraftment of NOD\/SCID mice by HIV vectors","volume":"283","author":"Miyoshi","year":"1999","journal-title":"Science"},{"key":"10.1038\/mt.2012.214_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1038\/mt.2012.214_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/38410","article-title":"Gene therapy \u2013 promises, problems and prospects","volume":"389","author":"Verma","year":"1997","journal-title":"Nature"},{"key":"10.1038\/mt.2012.214_bib23","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1182\/blood-2008-03-142661","article-title":"Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors","volume":"112","author":"Gonzalez-Murillo","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mt.2012.214_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0958-1669(02)00346-4","article-title":"Advances in lentiviral vector design for gene-modification of hematopoietic stem cells","volume":"13","author":"Logan","year":"2002","journal-title":"Curr Opin Biotechnol"},{"key":"10.1038\/mt.2012.214_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.214_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.gt.3302570","article-title":"Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors\u2013design, biosafety, and production","volume":"12","author":"Sinn","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.214_bib27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI200419205","article-title":"Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells","volume":"113","author":"Biffi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.214_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.732","article-title":"Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector","volume":"7","author":"Kim","year":"2005","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2012.214_bib29","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1182\/blood-2009-11-252874","article-title":"Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype","volume":"115","author":"van Til","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2012.214_bib30","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2012.214_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1038\/mt.2012.214_bib32","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.214_bib33","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/mt.2008.126","article-title":"Gene transfer may be preventive but not curative for a lysosomal transport disorder","volume":"16","author":"Hippert","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.214_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.186.4.619","article-title":"Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture","volume":"186","author":"Bhatia","year":"1997","journal-title":"J Exp Med"},{"issue":"suppl. 1","key":"10.1038\/mt.2012.214_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/stem.5530150826","article-title":"Assay of human stem cells by repopulation of NOD\/SCID mice","volume":"15","author":"Dick","year":"1997","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2012.214_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/hum.2005.16.81","article-title":"Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector","volume":"16","author":"Di Domenico","year":"2005","journal-title":"Hum Gene Ther"},{"issue":"5 Pt 1","key":"10.1038\/mt.2012.214_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/mthe.2000.0067","article-title":"Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression","volume":"1","author":"Kosuga","year":"2000","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.214_bib38","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1089\/10430349950017996","article-title":"Retrovirus vector-mediated correction and cross-correction of lysosomal alpha-mannosidase deficiency in human and feline fibroblasts","volume":"10","author":"Sun","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.214_bib39","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1471-4159.2005.03317.x","article-title":"Metabolic correction in microglia derived from Sandhoff disease model mice","volume":"94","author":"Tsuji","year":"2005","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2012.214_bib40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.2010.278","article-title":"Exosomes\/microvesicles as a mechanism of cell-to-cell communication","volume":"78","author":"Camussi","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2012.214_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/cib.3.5.12339","article-title":"Exosomes: Fit to deliver small RNA","volume":"3","author":"Zomer","year":"2010","journal-title":"Commun Integr Biol"},{"key":"10.1038\/mt.2012.214_bib42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1038\/mt.2012.214_bib43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1083\/jcb.200810038","article-title":"Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease","volume":"183","author":"Belting","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2012.214_bib44","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1634\/stemcells.2007-0128","article-title":"Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation","volume":"25","author":"Aliotta","year":"2007","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2012.214_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MNH.0b013e328332fb6f","article-title":"Paracrine\/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information","volume":"19","author":"Camussi","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/mt.2012.214_bib46","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.4049\/jimmunol.177.12.8476","article-title":"Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria","volume":"177","author":"Onfelt","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/mt.2012.214_bib47","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.214_bib48","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","article-title":"Physiological promoters reduce the genotoxic risk of integrating gene vectors","volume":"16","author":"Zychlinski","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.214_bib49","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ymthe.2006.02.013","article-title":"In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency","volume":"13","author":"Carbonaro","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.214_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-59745-409-4_25","article-title":"Retroviral insertion site analysis in dominant haematopoietic clones","volume":"506","author":"Kustikova","year":"2009","journal-title":"Methods Mol Biol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616306037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616306037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:13:23Z","timestamp":1777997603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616306037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1525001616306037"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.214","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Stem Cell Gene Therapy for the Multisystemic Lysosomal Storage Disorder Cystinosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2012.214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}